Literature DB >> 19636224

Sunitinib-induced thyrotoxicosis.

D Piñar, E Boix, J A Meana, J Herrero.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19636224     DOI： 10.1007/BF03345777

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  8 in total

1.  Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib.

Authors:  Brian I Rini; Ila Tamaskar; Phillip Shaheen; Renee Salas; Jorge Garcia; Laura Wood; Sethu Reddy; Robert Dreicer; Ronald M Bukowski
Journal:  J Natl Cancer Inst       Date:  2007-01-03       Impact factor: 13.506

2.  Sunitinib-associated lymphocytic thyroiditis without circulating antithyroid antibodies.

Authors:  Doru T Alexandrescu; Geanina Popoveniuc; Haleh Farzanmehr; Constantin A Dasanu; Nancy Dawson; Leonard Wartofsky
Journal:  Thyroid       Date:  2008-07       Impact factor: 6.568

3.  Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors.

Authors:  Jayesh Desai; Leila Yassa; Ellen Marqusee; Suzanne George; Mary C Frates; Ming Hui Chen; Jeffrey A Morgan; Samuel S Dychter; P Reed Larsen; George D Demetri; Erik K Alexander
Journal:  Ann Intern Med       Date:  2006-11-07       Impact factor: 25.391

4.  Sunitinib (sutent)-induced thyrotoxicosis due to destructive thyroiditis: a case report.

Authors:  Jason E Faris; Allan F Moore; Gilbert H Daniels
Journal:  Thyroid       Date:  2007-11       Impact factor: 6.568

5.  A novel tyrosine-kinase selective inhibitor, sunitinib, induces transient hypothyroidism by blocking iodine uptake.

Authors:  Deborah Mannavola; Paola Coco; Guia Vannucchi; Rossella Bertuelli; Marco Carletto; Paolo G Casali; Paolo Beck-Peccoz; Laura Fugazzola
Journal:  J Clin Endocrinol Metab       Date:  2007-06-26       Impact factor: 5.958

6.  Presence and possible role of vascular endothelial growth factor in thyroid cell growth and function.

Authors:  J F Wang; V Milosveski; C Schramek; G H Fong; G P Becks; D J Hill
Journal:  J Endocrinol       Date:  1998-04       Impact factor: 4.286

7.  Thyrotoxicosis during sunitinib treatment for renal cell carcinoma.

Authors:  Mathis Grossmann; Erosha Premaratne; Jayesh Desai; Ian D Davis
Journal:  Clin Endocrinol (Oxf)       Date:  2008-04-03       Impact factor: 3.478

8.  The clinical implications of sunitinib-induced hypothyroidism: a prospective evaluation.

Authors:  P Wolter; C Stefan; B Decallonne; H Dumez; M Bex; P Carmeliet; P Schöffski
Journal:  Br J Cancer       Date:  2008-08-05       Impact factor: 7.640
  8 in total
  1 in total

Review 1.  Thyroid dysfunction from antineoplastic agents.

Authors:  Ole-Petter Riksfjord Hamnvik; P Reed Larsen; Ellen Marqusee
Journal:  J Natl Cancer Inst       Date:  2011-10-18       Impact factor: 13.506
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.